# Methylphenidate on Intracortical Inhibition in Methamphetamine Abusers Attention Deficit Hyperactivity Disorder (ADHD)

> **NCT01651169** · NA · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **OTHER:** methylphenidate tablets and Inter-stimulus Intervals (ISI)
- **OTHER:** methylphenidate tablets and Inter-stimulus Intervals (ISI)

## Key facts

- **NCT ID:** NCT01651169
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2015-11
- **Final completion:** 2016-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651169, "Methylphenidate on Intracortical Inhibition in Methamphetamine Abusers Attention Deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01651169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*